Molecular analysis of new herpesvirusinfections

新疱疹病毒感染的分子分析

基本信息

  • 批准号:
    09670477
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Human herpesvirus 6 (HHV-6), HHV-7 and KSHV (HHV-8) are new human herpesviruses which have been recently isolated. In the present study, the pathogenesis of these herpesvirus infections was investigated focusing on the functional alteration of virus-infected CD4+T lymphocytes. Results obtained from the series of the present study are as follows :1. HHV-6 infection of CD4+T lymphocytes resulted in their apoptosis. The degree of apoptosis increased when HHV-6-inoculated cells were cultured in the presence of TNF-a and anti-Fas antibody. HHV-6 induces apoptosis in CD4^+T cells by indirect mechanisms, as reported recently in HIV-1 infection.2. We examined the susceptibility to HHV-7 infection of various CD4-negative cell lines into which the cDNA for CD4 was transferred using an adenovirus vector. Out of 13 cell lines transduced with Adex1CACD4, 4 cell lines showed high susceptibility to HHV-7 infection. These data suggest strongly that CD4 is a major component of the binding receptor for … More HHV-7.3. Two novel Ph chromosome-positive myeloid cell lines, SAS4l3 and SAS527, which possess different hematologic characteristics and show distinct susceptibility to infection of HHV-6, have been established. TPA-treatment of SAS527 which was latently infected with HHV-6B resulted in reactivation of HHV-6. These novel cell lines should be useful for studying the mechanisms of HHV-6- induced hematopoietic failure and HHV-6 latency and reactivation.4. Although CXCR4 and CCR5 appeared not to be the coreceptors for these viruses, marked down-regulation of CXCR4, but not CCR5, was detected in HHV-6 and HHV-7-infected cells. Down-regulation of CXCR4 resulted in impairment of chemotaxis and a decreased level of elevation of the intracellular Ca^<2+> concentration in response to SDF-1. Northern blot analysis of mRNAs extracted from HHV-6- and HHV-7-infected CD4^+T lymphocytes demonstrated a markedly decreased level of CXCR4 gene transcription, but post-transcriptional stability of CXCR4 mRNA was not significantly altered. Less
人类疱疹病毒6(HHV-6),HHV-7和KSHV(HHV-8)是对这些疱疹病毒感染的SIS的新人类疱疹病毒从现在的礼物中如下:1。N当HV-6插入的细胞在TNF-A和抗FAS抗体的存在下培养时凋亡程度增加。 .2。具有……更多HHV-7.3的结合受体。 6B的重新激活HV-6。 CCR5在HHV-7感染的细胞中被检测到CXCR4的离子,导致趋化性障碍,并降低了对SDF-1的细胞内Ca^<2+反应的升高。 HV-7感染的CD4^+T细胞表现出明显降低的CXCR4基因转录水平,但CXCR4 mRNA的转录后稳定性并未显着改变

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yasukawa, M., et al.: "Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7" Journal of Immunology. (in press.).
Yasukawa, M., et al.:“人疱疹病毒 6 (HHV-6) 和 HHV-7 下调 CXCR4”免疫学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasukawa,M.,et al.: "Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector ・・・・・" Journal of Virology. 71. 1708-1712 (1997)
Yasukawa, M., et al.:“用腺病毒载体转导的人疱疹病毒 7 感染淋巴和骨髓细胞系……”病毒学杂志 71. 1708-1712 (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inoue, Y., et al.: "Induction of T-cell apoptosis by human herpesvirus 6" Journal of Virology. 71. 3751-3759 (1997)
Inoue, Y., et al.:“人类疱疹病毒 6 诱导 T 细胞凋亡”病毒学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tohyama,M.,et al: "Severe hypersensitivity syndrome to sulfasalazine associated with reactivvation of human herpesvirus 6" Archives of Dermatology. 134. 1113-1117 (1998)
Tohyama,M.,等人:“与人类疱疹病毒 6 重新激活相关的柳氮磺吡啶严重过敏综合征”皮肤病学档案。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaki Yasukawa, et al.: "Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection" Journal of General Virology. 79. 143-147 (1998)
Masaki Yasukawa 等人:“人类疱疹病毒 6 感染中 CD4 T 淋巴细胞的凋亡”普通病毒学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YASUKAWA Masaki其他文献

Menin plays an critical role in the survival of antigen-specific activated CD8+ T cells
Menin 在抗原特异性激活的 CD8 T 细胞的存活中发挥着关键作用
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    YAMADA Takeshi;KANOH Makoto;MATSUMOTO Akira;YASUOKA Toshiaki;SUZUKI Junpei;MARUYAMA Saho;KUWAHARA Makoto;YASUKAWA Masaki;YAMASHITA Masakatsu
  • 通讯作者:
    YAMASHITA Masakatsu
A tumor suppressor Menin controls CD8 T cell senescence by regulating glutamine metabolism
肿瘤抑制因子 Menin 通过调节谷氨酰胺代谢来控制 CD8 T 细胞衰老
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SUZUKI Junpei;KUWAHARA;Makoto;YASUKAWA Masaki;YAMASHITA Masakatsu
  • 通讯作者:
    YAMASHITA Masakatsu
The tumor suppressor menin epigenetically regulates CD8 T cell senescence via the modulation of glutamine metabolism
肿瘤抑制蛋白 menin 通过调节谷氨酰胺代谢从表观遗传学角度调节 CD8 T 细胞衰老
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SUZUKI Junpei;KUWAHARA Makoto;YAMADA Takeshi;YASUKAWA Masaki;YAMASHITA Masakatsu
  • 通讯作者:
    YAMASHITA Masakatsu

YASUKAWA Masaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YASUKAWA Masaki', 18)}}的其他基金

Development of the novel gene-immunotherapy using artificial CTL targeting leukemia stem cells
使用人工CTL靶向白血病干细胞开发新型基因免疫疗法
  • 批准号:
    24390245
  • 财政年份:
    2012
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel cancer therapy using soluble T-cell receptor
使用可溶性 T 细胞受体开发新型癌症疗法
  • 批准号:
    23659489
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of cancer immunotherapy using co-transfer of cancer-specific TCR gene and chemokine receptor gene
利用癌症特异性TCR基因和趋化因子受体基因共转移开发癌症免疫疗法
  • 批准号:
    21390294
  • 财政年份:
    2009
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel hematopoietic stem cell transplantation using cancer-specific T-cell receptor gene transfer
使用癌症特异性 T 细胞受体基因转移的新型造血干细胞移植
  • 批准号:
    19390265
  • 财政年份:
    2007
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel immunogene therapy for hamatopietic malignancies
造血系统恶性肿瘤新型免疫基因疗法的开发
  • 批准号:
    17390278
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel immunogene therapy for hematopoietic malignancies
造血系统恶性肿瘤的新型免疫基因疗法
  • 批准号:
    15390301
  • 财政年份:
    2003
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of novel cancer-specific antigens and application for cellular imunotherapy of hematological malignancies
新型癌症特异性抗原的鉴定及其在血液恶性肿瘤细胞免疫治疗中的应用
  • 批准号:
    13470206
  • 财政年份:
    2001
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel immunogene therapy for hematological malignancies
血液系统恶性肿瘤新型免疫基因疗法的开发
  • 批准号:
    12557081
  • 财政年份:
    2000
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Immunogene therapy of cancer and virus infections using immortalized T-cell clones
使用永生化 T 细胞克隆对癌症和病毒感染进行免疫基因治疗
  • 批准号:
    11670449
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Abnormality of signal Transduction via T-cell receptors mediated by retrovirus infection
逆转录病毒感染介导的T细胞受体信号转导异常
  • 批准号:
    02670283
  • 财政年份:
    1990
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

HHV-6逃逸RLR/MAVS介导的天然免疫应答的机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
HHV-6通过调控宿主T细胞糖代谢促进病毒复制及免疫逃逸的机制研究
  • 批准号:
    32070945
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
人疱疹病毒6型U94/rep基因的表达在调控人神经胶质瘤发展中的作用
  • 批准号:
    81273235
  • 批准年份:
    2012
  • 资助金额:
    69.0 万元
  • 项目类别:
    面上项目
介导HIV-1 Tat协同HHV-6增强KSHV复制的信号转导通路鉴定
  • 批准号:
    30670096
  • 批准年份:
    2006
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

Investigation of chromosomally integrated Human Herpesvirus 6 as a risk factor for Alzheimer's disease
染色体整合人类疱疹病毒 6 作为阿尔茨海默病危险因素的研究
  • 批准号:
    9904309
  • 财政年份:
    2019
  • 资助金额:
    $ 1.92万
  • 项目类别:
Elucidation of the relationship between reproductive failure and human herpesvirus 6 and 7
阐明生殖障碍与人类疱疹病毒6型和7型之间的关系
  • 批准号:
    18K16799
  • 财政年份:
    2018
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
11th International Conference on human herpesviruses 6A, 6B and 7.
第 11 届人类疱疹病毒 6A、6B 和 7 国际会议。
  • 批准号:
    391960
  • 财政年份:
    2018
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Miscellaneous Programs
Analysis of HHV-6B primary infection in a cohort of febrile children under 5 years old
5岁以下发热儿童HHV-6B原发感染分析
  • 批准号:
    17K16283
  • 财政年份:
    2017
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Study on the refractory mechanism in inflammatory obstructive lung disease
炎症性阻塞性肺疾病的难治机制研究
  • 批准号:
    15K09233
  • 财政年份:
    2015
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了